We are being courted by a family office that claims to offer a patient capital model, but their initial valuation multiple is lower than what private equity sponsors are pitching. How do we evaluate the trade-off between a family office's long-term hold period and a financial sponsor's aggressive equity growth expectations?

Question

Tyler Smith · Accepted Answer

Family offices and private equity sponsors represent two very different transaction paths. Family offices operate with patient capital, meaning they have long hold periods and are not pressured to flip your company in five years. However, because they are not looking for rapid, leveraged exits, they often offer lower valuation multiples and structure their deals with less leverage and more conservative terms.

Private equity sponsors are driven by strict fund lifecycles, typically requiring an exit in three to seven years. They will pay higher multiples but will demand aggressive growth targets and may layer significant debt onto your business. This pressure can cause immense stress for the leadership team you leave behind.

To evaluate these offers, look at your V/TO®. If your long-term vision requires a partner who will support steady, sustainable growth without the disruption of a secondary sale, the lower multiple of a family office might be worth the peace of mind. If you want to maximize your valuation and your leadership team is energized by the prospect of a high-growth, leveraged scale-up, a private equity sponsor is the better fit. Use the GWC™ tool to assess whether your leadership team is truly equipped to handle the intense pressure of a PE-backed environment.